Cargando…
Efficacy of the Unani Regimen as an Add-On to Standard Treatment in Hospitalised RT-PCR-Confirmed Mild to Moderate COVID-19 Patients: An Open-Label Randomized Controlled Trial
Background The coronavirus disease 2019 (COVID-19) pandemic resulted in mortality and morbidity worldwide. Many treatment modalities have been experimented with limited success. Therefore, the traditional system of medicine needs to be explored. Objective To evaluate the benefits of Unani regimensTi...
Autores principales: | Kishore, Jugal, Kumar, Rohit, Nazli, Tamanna, Ahmad, Aftab, Kumar, Pawan, Khan, Asim A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239565/ https://www.ncbi.nlm.nih.gov/pubmed/37284399 http://dx.doi.org/10.7759/cureus.38574 |
Ejemplares similares
-
Awareness and Utilization of Unani Medicine among the Adult Population from East Delhi: A cross Sectional Survey
por: Khan, Asim Ali, et al.
Publicado: (2022) -
Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry
por: Khedar, Raghubir Singh, et al.
Publicado: (2022) -
GERIATRICS AND UNANI MEDICINE – A CRITICAL REVIEW
por: Hussain, Syed Asif, et al.
Publicado: (2002) -
Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised children
por: Schober, Tilmann, et al.
Publicado: (2022) -
A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis
por: Khanna, Neena, et al.
Publicado: (2018)